Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilena Sitnilska

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 27, 2017
Early Changes of Retinal Morphology in Therapy of Neovascular Age-Related Macular Degeneration with Three Commonly Used Anti-VEGF AgentsPhilip Enders, Vasilena Sitnilska, Lebriz Altay, et al.
BMC Ophthalmology|January 4, 2024
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathyVasilena Sitnilska, Petra Schiller, Tim U Krohne, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2020
Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degenerationVasilena Sitnilska, Philip Enders, Claus Cursiefen, et al.
Die Ophthalmologie|February 7, 2025
[Treatment of central serous chorioretinopathy in comparison-Micropulse laser versus photodynamic therapy]Vasilena Sitnilska, Ulrike Brocks, Jan Tode, et al.
Die Ophthalmologie|April 22, 2026
Treatment of central serous chorioretinopathy in comparison-microsecond-pulse laser versus photodynamic therapyVasilena Sitnilska, Ulrike Brocks, Jan Tode, et al.
Retina (Philadelphia, Pa.)|June 18, 2014
Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretionRobert Hoerster, Philipp S Muether, Vasilena Sitnilska, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMYPaula Scholz, Vasilena Sitnilska, Jelka Hess, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|October 11, 2018
Onset of Retinal Pigment Epithelium Atrophy Subsequent to Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular DegenerationVasilena Sitnilska, Lebriz Altay, Philip Enders, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 1, 2017
Retinal Nerve Fiber Loss in Anti-VEGF Therapy for Age-Related Macular Degeneration Can Be Decreased by Anterior Chamber ParacentesisPhilip Enders, Vasilena Sitnilska, Lebriz Altay, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 18, 2025
Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid NeovasculopathyVasilena Sitnilska, Johannes Maximillian Pohl, Yuhe Tang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 27, 2017
Early Changes of Retinal Morphology in Therapy of Neovascular Age-Related Macular Degeneration with Three Commonly Used Anti-VEGF AgentsPhilip Enders, Vasilena Sitnilska, Lebriz Altay, et al.
BMC Ophthalmology|January 4, 2024
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathyVasilena Sitnilska, Petra Schiller, Tim U Krohne, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 3, 2020
Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degenerationVasilena Sitnilska, Philip Enders, Claus Cursiefen, et al.
Die Ophthalmologie|February 7, 2025
[Treatment of central serous chorioretinopathy in comparison-Micropulse laser versus photodynamic therapy]Vasilena Sitnilska, Ulrike Brocks, Jan Tode, et al.
Die Ophthalmologie|April 22, 2026
Treatment of central serous chorioretinopathy in comparison-microsecond-pulse laser versus photodynamic therapyVasilena Sitnilska, Ulrike Brocks, Jan Tode, et al.
Retina (Philadelphia, Pa.)|June 18, 2014
Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretionRobert Hoerster, Philipp S Muether, Vasilena Sitnilska, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMYPaula Scholz, Vasilena Sitnilska, Jelka Hess, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|October 11, 2018
Onset of Retinal Pigment Epithelium Atrophy Subsequent to Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular DegenerationVasilena Sitnilska, Lebriz Altay, Philip Enders, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 1, 2017
Retinal Nerve Fiber Loss in Anti-VEGF Therapy for Age-Related Macular Degeneration Can Be Decreased by Anterior Chamber ParacentesisPhilip Enders, Vasilena Sitnilska, Lebriz Altay, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 18, 2025
Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid NeovasculopathyVasilena Sitnilska, Johannes Maximillian Pohl, Yuhe Tang, et al.
Pageof 2